| |
|
|
|
|
|
|
|
|
|
Article Tools:
|
|
Tuesday, August 31st, 2010 Of the paradigms that govern the treatment of breast cancer that is most accepted is that of the treatment of metastatic breast cancer that is HER-2 positive. For these patients, chemotherapy with trastuzumab is the gold standard.
Tuesday, August 3rd, 2010 A common concern of women recovering from cancer surgery and treatment is the risks and benefits of exercise. Is it safe? Is it a good idea? For women who have their lymph nodes removed as part of their cancer surgery, an added concern is, will I be at an increased risk of lymphedema?
Tuesday, June 15th, 2010 Now that ASCO has concluded, I'd like to review the data from GOG 218, the three-arm randomized trial that evaluated the role of bevacizumab in the first-line treatment of ovarian cancer.
Thursday, June 3rd, 2010 The American Society of Clinical Oncology held a presscast of studies to presented this coming June, and one has caught the attention of news organizations worldwide. It is a study of a two-step ovarian cancer screening program, conducted by MD Anderson Cancer Center.
Thursday, May 20th, 2010 Sentinel node biopsy in the axilla as part of breast cancer surgery is standard of care. It has spared women from the requirement of a full axillary dissection, where many nodes are removed with resultant risks of long-term complications, such as arm swelling, or lymphedema.
Tuesday, April 27th, 2010 What role inflammation, and in turn the use of anti-inflammatory agents, has in changing the risk of ovarian cancer was the topic of an interesting presentation at the recent AACR meeting.
Article Tools:
|
|
|
|
|
| 
 Don S. Dizon, MD, FACP Dr. Dizon is the Director of Medical Oncology, Integrative Care, and Co-Director of the Center for Sexuality, Intimacy and Fertility at the Program in Women's Oncology at Women and Infants Hospital of Rhode Island. His practice is tailored to breast and gynecologic malignancies and he remains active in clinical research through the Gynecologic Oncology Group and Brown University Oncology Group. He is an Associate Professor of Obstetrics-Gynecology and Associate Professor of Medicine at Alpert Medical School of Brown University. The Women's Cancer Blog Don S. Dizon, MD, FACP This blog will focus on new developments in these fields as reported from national meetings and publications to bring a non-physician perspective to the revolution ongoing in the diagnosis and management of women's oncology.
|
|
|
| |
|
Intellisphere, LLC l 666 Plainsboro Road, Building 300, Plainsboro, NJ 08536 l P 609-716-7777 l F 609-716-4747
|
 |
|
Copyright ©MDNG 2006-2010
Intellisphere, LLC
All Rights Reserved
|
|
|
|
|
|
